Edwards Lifesciences (NYSE: EW), a leader in global structural heart innovation, is excited to announce the successful closing of a funding round totaling $4.2 billion. This substantial capital infusion will empower the company to accelerate its mission of delivering transformative medical technologies aimed at improving patient outcomes worldwide. Edwards Lifesciences is dedicated to advancing cardiovascular care through groundbreaking solutions designed specifically for structural heart therapy, and this funding will play a pivotal role in expanding our research and development initiatives. With a focus on innovating treatment modalities that cater to the needs of patients in over 100 countries, we are driven by a deep-rooted passion to enhance lives through pioneering medical advancements. The funds will also support collaborations with healthcare providers and enhance our clinical affairs, ensuring that we continue to uphold the highest standards of quality and efficacy in our products. Our dedicated team, comprising professionals in Clinical Affairs, Quality Engineering, Research & Development, Sales & Marketing, and more, is committed to pushing the boundaries of what's possible in medical technology. As we move forward with this investment, we remain resolute in our commitment to providing life-changing innovations that truly make a difference for patients in need. This funding marks a significant milestone in our journey, and we look forward to sharing the fruits of our labor with our community and stakeholders as we strive for excellence in healthcare.
Breaking News: Edwards Lifesciences Critical Care Secures $4.2 Billion in Funding
Get the full Edwards Lifesciences Critical Care company profile
Access contacts, investors, buying signals & more
Other recently funded companies
View all
Synaps
Synaps is your creative playground for architectural design in the AI era. We’re building a radically new design platform, where ideas move at the speed of thought, creativity is collaborative, and AI enhances imagination instead of replacing it. From sketch to floor plan, facade to render, Synaps makes architectural design fluid, playful, and fast... all within your browser.
$3.6M Pre-seed
today
Skydio
Skydio is the leading U.S.-based drone manufacturer and the world leader in autonomous flight technology. We leverage breakthrough artificial intelligence to create flying robots that are easier to operate, safer to fly, and more capable in complex environments. Our systems are trusted by more than 3,800 agencies and organizations across the U.S. military, public safety, and critical infrastructure sectors. Skydio Drone as First Responder (DFR) programs now operate in 42 states, and more than 16M Americans live within the response zone of a DFR Dock. In total, Skydio supports more than 1,200 public safety agencies – double the number from a year ago. More than 250 utilities rely on Skydio for inspection programs that improve reliability and worker safety. In national security, they are supporting mission-critical operations both on the battlefield and across military installations, keeping our nation and our allies secure. Founded in 2014, Skydio designs, assembles, and supports its products in the U.S., with headquarters in San Mateo, CA, and manufacturing facilities in Hayward, CA. We are the largest drone manufacturer in the U.S. and have shipped more than 60,000 flying robots. The company is backed by top investors and strategic partners, including Andreessen Horowitz, Linse Capital, N47, IVP, Playground, and NVIDIA.
$110.0M Series f
today
Illuminant Surgical
Illuminant Surgical is building a new way of seeing inside the human body. Our breakthrough platform, Skylight™, is the first real-time anatomical projection system, displaying images directly on the patient to give doctors an x-ray vision view for safer interventions.
$8.4M Seed
today
All3
All3 is a construction technology company that’s redefining how buildings are designed and built. By combining AI-powered design with robotic fabrication, All3 enables developers to deliver custom, sustainable buildings at the cost and speed of mass production. At its core, All3 is about solving the construction industry’s biggest challenges - low productivity resulting in high costs, and environmental impact - by bringing the precision and productivity of advanced automation to the built environment. In essence, All3 isn’t just a construction company - it’s a technology-driven enabler that empowers architects to design freely, developers to build more efficiently, and communities to access high-quality, sustainable housing.
$25.0M Seed
today
Photon
We're building a modern prescription network that empowers people to shop with their prescriptions in hand.
$16.0M Series a
today